HTL Biotechnology is listed on the portfolio pages of Bridgepoint Group (portfolio page) and Montagu Private Equity (portfolio page). Bridgepoint Group and Montagu Private Equity list it as current.
HTL Biotechnology is a Healthcare company. Its owner on record, Bridgepoint Group, is a private equity firm founded in 1984, headquartered in London, England, with £38.8 billion under management. Bridgepoint Group lists 176 companies in the index, 11 of them in Healthcare. Also backed by Montagu Private Equity.
Bridgepoint Group is a British private investment company that specializes in private equity and credit, listed on the London Stock Exchange.
Read the Bridgepoint Group profileMontagu Private Equity is a carve-out specialist that invests in businesses providing must-have products and services.
Read the Montagu Private Equity profileHTL Biotechnology is listed on the portfolio pages of Bridgepoint Group (portfolio page) and Montagu Private Equity (portfolio page). Bridgepoint Group and Montagu Private Equity list it as current.
HTL Biotechnology is in Healthcare. Classified from the owner's portfolio label.
Bridgepoint Group is headquartered in London, England.
Bridgepoint Group lists 10 other Healthcare companies in the index, including Aenova, Altano Group, Attendo, Avalere Health (formerly Fishawack) and Axplora.
6 of 175 shown
See the full Bridgepoint Group portfolio.
6 of 55 shown
See the full Montagu Private Equity portfolio.
Browse PE-backed companies.